Unlike in previous studies focused on survival, our objective was to determine PON1 activity in critically ill patients with MODS and to put it in the context of the clinical type, ongoing inflammation, invading pathogen, infection site, and specific organ failure. This evidence concerns the gene PON1 and infection.